Literature DB >> 21105947

The inalienable right to withdraw from research.

Terrance McConnell1.   

Abstract

Most codes of research ethics and the practice of Institutional Review Boards (IRBs) allow human subjects to withdraw from research at any time. Consent forms invariably make a statement to this effect. So understood, a subject's right to withdraw from research is inalienable; she cannot, through her consent, surrender this right. Recently critics have argued that in selected circumstances the right to withdraw from research is alienable; subjects have the moral authority, through their consent, to obligate themselves not to withdraw. Two kinds of cases have been cited to support this. In one case, there will be great benefits lost if subjects are permitted to withdraw before the completion of the protocol. In the other case, there will be harm to third parties if subjects withdraw from the experiment. In this paper, I defend the inalienability of the right to withdraw from research. I argue, first, that securing the desired benefits and avoiding the feared harms can be achieved without allowing waiver. Second, I show that permitting waiver in these cases does not guarantee that the ends sought will be achieved. And third, I articulate positive reasons for conceiving subjects' right to withdraw from research as inalienable.
© 2010 American Society of Law, Medicine & Ethics, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21105947     DOI: 10.1111/j.1748-720X.2010.00537.x

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


  4 in total

1.  Withdrawing from research: a rethink in the context of research biobanks.

Authors:  Søren Holm
Journal:  Health Care Anal       Date:  2011-09

2.  Participants' responsibilities in clinical research.

Authors:  David B Resnik; Elizabeth Ness
Journal:  J Med Ethics       Date:  2012-07-19       Impact factor: 2.903

3.  Conflicts among multinational ethical and scientific standards for clinical trials of therapeutic interventions.

Authors:  Jacob M Kolman; Nelda P Wray; Carol M Ashton; Danielle M Wenner; Anna F Jarman; Baruch A Brody
Journal:  J Law Med Ethics       Date:  2012       Impact factor: 1.718

Review 4.  Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy.

Authors:  Euzebiusz Jamrozik; Michael J Selgelid
Journal:  J Med Ethics       Date:  2020-05-07       Impact factor: 2.903

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.